<DOC>
	<DOCNO>NCT00334425</DOCNO>
	<brief_summary>To evaluate effect LH-activity supplementation early follicular phase GnRHa down-regulated woman undergo IVF term S-Estradiol level hCG day compare different combination HP-HMG r-FSH .</brief_summary>
	<brief_title>The Effect LH-Priming During Early Follicular Phase IVF Treatment .</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Females age 18 38 year ( include ) time randomisation Patients treatment gonadotrophin GnRH agonist ( long protocol ) IVF set consider appropriate accord criterion participate centre Infertility least 1 year randomisation ( except tubal infertility ) A maximum two previous consecutive unsuccessful IVF cycle ( i.e . result ongoing pregnancy 25 34 day menstruation cycle Body mass index ( BMI ) &lt; 29 kg/m2 Any clinically significant systemic disease ( e.g. , insulin dependent diabetes ) Endocrine metabolic abnormality ( pituitary , adrenal , thyroid , pancreas , liver , kidney ) compromise participation study Any concomitant medication would interfere evaluation study medication . Specifically , nonstudy hormonal therapy ( except thyroid medication ) , prostaglandin inhibitor ( NSAIDs , include aspirin ) psychotropic agent ( phenothiazine ’ , major tranquilliser ) time study entry . Note : medication disallow study duration . Presence clinically significant uterine fibroid Undiagnosed vaginal bleeding Tumours ovary , breast , uterus , adrenal gland , pituitary hypothalamus Pregnancy , lactation contraindication pregnancy – must confirm negative urinary pregnancy test randomisation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>